MUM1(multiple myeloma oncogene-1) also known as IRF4(interferon regulatory factor 4) is a member of the interferon regulatory factor family and has been suggested as a potential therapeutic target in Peripheral T-cell lymphoma (PTCL) due to its expression in T-cell lymphoma [37, 38]. Here, IRF4 is linked to T-cell non-Hodgkin lymphoma.